Correlation Between Pfizer and Indaptus Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Indaptus Therapeutics, you can compare the effects of market volatilities on Pfizer and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Indaptus Therapeutics.

Diversification Opportunities for Pfizer and Indaptus Therapeutics

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pfizer and Indaptus is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and Indaptus Therapeutics go up and down completely randomly.

Pair Corralation between Pfizer and Indaptus Therapeutics

Considering the 90-day investment horizon Pfizer is expected to generate 5.95 times less return on investment than Indaptus Therapeutics. But when comparing it to its historical volatility, Pfizer Inc is 3.44 times less risky than Indaptus Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Indaptus Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  85.00  in Indaptus Therapeutics on November 3, 2024 and sell it today you would earn a total of  6.00  from holding Indaptus Therapeutics or generate 7.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Indaptus Therapeutics

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Indaptus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Indaptus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pfizer and Indaptus Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Indaptus Therapeutics

The main advantage of trading using opposite Pfizer and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.
The idea behind Pfizer Inc and Indaptus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk